Evidence map›Paper›PMID 40657327›Full record

ArticleJournal of diabetes and metabolic disorders2025

Type 5 diabetes as a growing malnutrition driven health crisis in low and middle income countries.

Jongky Hendro Prajitno, Henry Sutanto

Abstract readEditorial
In one paragraph

Article in Journal of diabetes and metabolic disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jongky Hendro PrajitnoDivision of Endocrinology, Metabolic Diseases and Diabetes, Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
Henry SutantoInternal Medicine Study Program, Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 5 diabetes mellitus (T5DM), recently redefined as malnutrition-related diabetes, represents a distinct form of severe insulin-deficient diabetes that arises from chronic undernutrition, particularly during childhood and adolescence. Unlike type 1 and type 2 diabetes, T5DM is neither autoimmune-mediated nor primarily driven by insulin resistance. Instead, it results from impaired pancreatic development and disrupted insulin signaling pathways due to prolonged nutritional deficiencies. This commentary proposes the formal adoption of "malnutrition-related diabetes" as the nomenclature for T5DM to more accurately reflect its etiology and clinical features. The condition is disproportionately prevalent in low and middle income countries, where malnutrition remains widespread and access to advanced diabetes care is limited. Accurate recognition and classification of T5DM are critical for developing appropriate diagnostic criteria, management strategies, and public health policies. Treatment typically focuses on nutritional rehabilitation and cost-effective oral antidiabetic therapies, rather than insulin dependence. Establishing malnutrition-related diabetes as a distinct category will support targeted research, improve patient outcomes, and raise awareness of its growing burden in vulnerable populations. This commentary urges the global health community to recognize malnutrition-related diabetes as a pressing metabolic disorder requiring urgent attention in low resource settings. Supplementary Information: The online version contains supplementary material available at 10.1007/s40200-025-01674-w.

Indexed as

Diabetes mellitusLow and middle income (developing) countriesMalnutritionMetabolic diseaseType 5 diabetes

Identifiers

PMID40657327
PMCPMC12246272

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.